Has Manisha Shroff, MD received payments from drug or device companies?

Yes. Drug and device makers reported $575 in general payments to Manisha Shroff, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manisha Shroff, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manisha Shroff, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manisha Shroff, MD

Psychiatry · Atlanta, GANPI 1699708750

Payments from drug & device makers

$575in general payments, 2019–2025

Across 27 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$142
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$74
Teva Pharmaceuticals USA, Inc.$64
Neurocrine Biosciences, Inc.$61
Otsuka America Pharmaceutical, Inc.$53
Indivior Inc.$44
plus $136 from 4 others

What the payments were for

Food & beverage$52892%
Education$478%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	7	$142
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$74
Teva Pharmaceuticals USA, Inc.	3	$64
Neurocrine Biosciences, Inc.	3	$61
Otsuka America Pharmaceutical, Inc.	3	$53
Indivior Inc.	2	$44
Johnson & Johnson	2	$44
Sunovion Pharmaceuticals Inc.	2	$42
Analog Devices Inc.	1	$34
Avanir Pharmaceuticals, Inc.	1	$17

How this compares

$575 in reported general payments places this provider in the 55th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia →

Medicare billing

Part B allowed, 2024

$14,867

Medicare patients

Services billed

225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	24	$540
Clonazepam	61	$513
Venlafaxine Hcl ErVenlafaxine Hcl	18	$423
Bupropion XlBupropion Hcl	33	$414
Buspirone Hcl	29	$356
Escitalopram Oxalate	22	$289
Mirtazapine	12	$184
Alprazolam	29	$170
Lamotrigine	16	$159
Trazodone Hcl	31	$138
Sertraline Hcl	12	$46

Paid to pharmacies, not to this prescriber.

Other psychiatry in Atlanta

Robert RiesenbergAtlanta$51.1M
Saundra Maass-RobinsonAtlanta$11.1M
David PurselleAtlanta$7.4M
Bethany DavisAtlanta$4.4M
Patricio Riva PosseAtlanta$884K
Kerry ResslerAtlanta$365K
Boadie DunlopAtlanta$345K
Michael BurkeAtlanta$328K
Bryon EvansAtlanta$211K
Nurul HoqueAtlanta$145K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →